SARS-CoV-2 infection has been reported to induce a hypercoagulable state1 which is associated with disease severity and poor outcomes.2,3 Rates of thromboembolic events and use of augmented thromboprophylaxis in patients with COVID-19 are therefore the subject of significant interest. However, the clinical manifestations of this procoagulant tendency are poorly defined. In this report we describe two cases of major occlusive arterial events in previously asymptomatic individuals with confirmed COVID-19.